Cabotegravir (image) Rockefeller University Share Print E-Mail Caption The new drug cabotegravir (in vials above) has been shown to protect monkeys from infection by an HIV-like virus, and a clinical trial testing cabotegravir's safety and acceptability has begun. Unlike other preventive treatments, it would require only one injection every three months. Credit Zach Veilleux / The Rockefeller University Usage Restrictions Image may be used only to illustrate the research described in the accompanying story. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.